Ilex Medical Ltd (TLV:ILX)
Israel
· Delayed Price · Currency is ILS · Price in ILA 6,415.00
-4.00 (-0.06%)
At close: Dec 4, 2025
Ilex Medical Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 3, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 718 | 842 | 663 | 1,081 | 1,834 | 1,388 | Upgrade
|
| Market Cap Growth | -3.19% | 27.01% | -38.64% | -41.07% | 32.20% | 65.99% | Upgrade
|
| Enterprise Value | 527 | 716 | 555 | 926 | 1,705 | 1,341 | Upgrade
|
| Last Close Price | 64.15 | 73.18 | 56.46 | 89.88 | 147.07 | 105.90 | Upgrade
|
| PE Ratio | 14.77 | 21.61 | 13.04 | 10.58 | 9.29 | 11.50 | Upgrade
|
| PS Ratio | 0.78 | 0.92 | 0.72 | 1.25 | 1.73 | 1.47 | Upgrade
|
| PB Ratio | 1.07 | 1.30 | 1.06 | 1.76 | 3.19 | 3.13 | Upgrade
|
| P/TBV Ratio | 1.10 | 1.35 | 1.11 | 1.86 | 3.34 | 3.37 | Upgrade
|
| P/FCF Ratio | 8.38 | 16.24 | 20.95 | 24.79 | 7.98 | 10.05 | Upgrade
|
| P/OCF Ratio | 6.51 | 10.32 | 8.25 | 15.50 | 6.78 | 7.61 | Upgrade
|
| EV/Sales Ratio | 0.58 | 0.78 | 0.61 | 1.07 | 1.61 | 1.42 | Upgrade
|
| EV/EBITDA Ratio | 5.43 | 7.40 | 5.00 | 4.72 | 5.75 | 7.20 | Upgrade
|
| EV/EBIT Ratio | 10.83 | 11.37 | 7.16 | 6.33 | 6.93 | 9.15 | Upgrade
|
| EV/FCF Ratio | 6.15 | 13.80 | 17.52 | 21.25 | 7.42 | 9.71 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.08 | 0.08 | 0.08 | 0.10 | 0.15 | Upgrade
|
| Debt / EBITDA Ratio | 0.46 | 0.47 | 0.39 | 0.26 | 0.20 | 0.36 | Upgrade
|
| Debt / FCF Ratio | 0.57 | 0.99 | 1.52 | 1.18 | 0.26 | 0.48 | Upgrade
|
| Asset Turnover | 0.93 | 0.92 | 0.96 | 0.97 | 1.28 | 1.39 | Upgrade
|
| Inventory Turnover | 4.09 | 4.43 | 4.51 | 4.43 | 5.39 | 6.04 | Upgrade
|
| Quick Ratio | 1.98 | 1.88 | 1.86 | 2.11 | 2.12 | 1.49 | Upgrade
|
| Current Ratio | 2.86 | 2.68 | 2.46 | 2.81 | 2.63 | 2.00 | Upgrade
|
| Return on Equity (ROE) | 7.38% | 7.20% | 8.98% | 18.25% | 38.76% | 32.85% | Upgrade
|
| Return on Assets (ROA) | 3.60% | 3.91% | 5.06% | 10.31% | 18.60% | 13.46% | Upgrade
|
| Return on Capital (ROIC) | 5.02% | 5.74% | 7.25% | 14.08% | 26.88% | 19.68% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.80% | 8.70% | 10.50% | 21.70% | 38.80% | 29.30% | Upgrade
|
| Earnings Yield | 6.08% | 4.63% | 7.67% | 9.45% | 10.77% | 8.69% | Upgrade
|
| FCF Yield | 11.93% | 6.16% | 4.77% | 4.03% | 12.53% | 9.95% | Upgrade
|
| Dividend Yield | 1.90% | 1.67% | 2.42% | 2.13% | 3.62% | 5.02% | Upgrade
|
| Payout Ratio | 31.27% | 39.16% | 42.14% | 58.75% | 30.38% | - | Upgrade
|
| Buyback Yield / Dilution | 0.18% | 0.02% | 0.79% | 0.02% | -5.73% | -6.33% | Upgrade
|
| Total Shareholder Return | 2.08% | 1.68% | 3.21% | 2.15% | -2.11% | -1.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.